Protagonist Therapeutics OverviewProtagonist Therapeutics Other Income Expense Net
Other Income/Expense Net for PTGX.
Quarterly Other Income/Expense
$5.93M
↓ 22.55% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$27.09M
↓ 9.29% YoY
Trailing 12 months ending Mar 31, 2026